| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.naxparlab.com | |
| Market Cap | 148.22 Cr. | |
| Enterprise Value(EV) | 195.85 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 7.67 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 16.83 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.22 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 60.53 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.13 | Calculated using Price: 129.05 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.15 Cr. | 11,485,616 Shares |
| FaceValue | 10 | |
| About Parnax Lab Ltd. | ||
| Parnax Lab, earlier known as Krishnadeep Trade and Investments, incorporated in the year 1982, engages in investing and financial businesses in India. The company is based in Mumbai, India. In 2012 the company has changed its name from Krishna Deep Trade & Investments Ltd. to Parnax Lab Ltd. " | ||
| 1 Day |
|
+1.45% |
| 1 Week |
|
-5.22% |
| 1 Month |
|
-0.62% |
| 3 Month |
|
+37.47% |
| 6 Month |
|
+49.67% |
| 1 Year |
|
+83.11% |
| 2 Year |
|
-9.28% |
| 5 Year |
|
+293.89% |
| 10 Year |
|
+186.03% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 18.5 | 9.5 | 12.51 | 3.31 | 9.69 | -8.51 | -1.11 | 20.93 | 15.91 | |
| Return on Capital Employed (%) | 16.35 | 11.47 | 13.73 | 10.49 | 11.59 | 3.27 | 5.83 | 17.34 | 15.2 | |
| Return on Assets (%) | 5.12 | 3.09 | 4.48 | 1.22 | 3.63 | -2.89 | -0.34 | 6.36 | 5.78 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 25 | 28 | 31 | 33 | 36 | 33 | 33 | 48 | 62 | 67 | |
| Non Curr. Liab. | 27 | 23 | 18 | 18 | 23 | 22 | 19 | 24 | 20 | 24 | |
| Curr. Liab. | 31 | 29 | 36 | 37 | 36 | 52 | 54 | 81 | 63 | 66 | |
| Minority Int. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Equity & Liab. | 83 | 79 | 86 | 87 | 95 | 107 | 106 | 153 | 145 | 158 | |
| Non Curr. Assets | 45 | 49 | 55 | 51 | 58 | 62 | 67 | 79 | 84 | 92 | |
| Curr. Assets | 38 | 31 | 31 | 36 | 37 | 42 | 36 | 71 | 57 | 66 | |
| Misc. Exp. not W/O | 0 | ||||||||||
| Total Assets | 83 | 79 | 86 | 87 | 95 | 107 | 106 | 153 | 145 | 158 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 103 | 71 | 95 | 106 | 109 | 95 | 90 | 163 | 168 | 183 | |
| Other Income | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | |
| Total Income | 104 | 72 | 96 | 107 | 111 | 96 | 90 | 163 | 168 | 184 | |
| Total Expenditure | -91 | -61 | -82 | -96 | -99 | -89 | -80 | -140 | -145 | -161 | |
| PBIDT | 13 | 11 | 13 | 11 | 12 | 7 | 10 | 23 | 24 | 23 | |
| Interest | -4 | -4 | -5 | -4 | -4 | -5 | -5 | -5 | -5 | -5 | |
| Depreciation | -3 | -3 | -4 | -4 | -4 | -4 | -5 | -6 | -7 | -7 | |
| Taxation | -1 | -1 | -1 | -2 | -1 | -1 | 0 | -4 | -4 | -3 | |
| Exceptional Items | |||||||||||
| PAT | 4 | 3 | 4 | 1 | 3 | -3 | 0 | 8 | 9 | 9 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 4 | 3 | 4 | 1 | 3 | -3 | 0 | 8 | 9 | 9 | |
| Adjusted EPS | 5 | 3 | 4 | 1 | 4 | -3 | 0 | 8 | 8 | 8 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 3 | 16 | 13 | 9 | 9 | 6 | 9 | 21 | |
| Cash Fr. Inv. | -6 | -4 | -6 | -10 | -5 | -11 | -13 | -7 | -17 | -10 | |
| Cash Fr. Finan. | 6 | 6 | 1 | -5 | -7 | 1 | 5 | 0 | 12 | -14 | |
| Net Change | 0 | 1 | -2 | 0 | 1 | -1 | 0 | 0 | 4 | -3 | |
| Cash & Cash Eqvt | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 1 |
|
Fri, 12 Apr 2024
Certificate As Per Regulation 40(9) Of The Listing Obligations And Disclosure Requirement Regulation 2015 For The Year Ended 31St March 2024. Please find enclosed herewith the Certificate as per Regulation 40(9) of LODR Regulation 2015 for the year ended March 31 2024.Kindly take the same on your record. |
|
Thu, 11 Apr 2024
Compliance Certificate For The Period Ended March 31 2024. Please find enclosed herewith the Certificate as per Regulation 7 (3) of the Listing Obligations and Disclosure Requirement Regulation 2015 for the year ended March 31 2024. |
|
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 We have received confirmation certificate from our RTA i.e. Link Intime India Pvt. Ltd. that there were no dematerialization received during the quarter ended Mach 31 2024. Also enclosed Confirmation Certificate for the same. |
| Wed, 24 Apr 2024 |
High Increase in 3 Months
|
High Increase in 6 Months
|
High Increase in 1 Year
|
High Increase in 5 Years
|
RSI Trending Up
|
